Mercer Global Advisors’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$397K Buy
6,966
+1,076
+18% +$62.4K ﹤0.01% 2172
2025
Q4
$298K Buy
5,890
+64
+1% +$3.27K ﹤0.01% 2233
2025
Q3
$291K Buy
+5,826
New +$267K ﹤0.01% 2105
2024
Q3
Sell
-12,969
Closed -$401K 2036
2024
Q2
$401K Buy
12,969
+1,969
+18% +$62.4K ﹤0.01% 1424
2024
Q1
$393K Buy
11,000
+1,909
+21% +$68.9K ﹤0.01% 1415
2023
Q4
$354K Buy
+9,091
New +$294K ﹤0.01% 1512
2021
Q2
Sell
-200
Closed -$24K 1728
2021
Q1
$24K Buy
+200
New +$33.3K ﹤0.01% 1603
2020
Q1
Sell
-4,698
Closed -$477K 1217
2019
Q4
$477K Sell
4,698
-2,111
-31% -$209K 0.01% 749
2019
Q3
$695K Buy
6,809
+1,062
+18% +$108K 0.02% 586
2019
Q2
$667K Sell
5,747
-151
-3% -$16.3K 0.02% 587
2019
Q1
$620K Buy
+5,898
New +$662K 0.02% 564

Other funds holding PRLB

Mercer Global Advisors's PRLB Position: Q1 2026 in Review

Mercer Global Advisors increased its Protolabs (PRLB) stake by 18% in Q1 2026, buying an estimated $62.4K and bringing the position to 6,966 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

Mercer Global Advisors first reported a position in PRLB in Q1 2019 and has held it in 11 quarters since. The position peaked at $695K in Q3 2019. 262 funds tracked by Wall St. Rank hold PRLB as of Q1 2026.

  • Mercer Global Advisors held 6,966 shares of Protolabs worth $397K as of Q1 2026.
  • Mercer Global Advisors bought 1,076 Protolabs shares in Q1 2026, an estimated $62.4K.
  • Protolabs made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2172 holding.
  • Mercer Global Advisors first reported a position in Protolabs in Q1 2019 and has held it in 11 quarters since.
  • Mercer Global Advisors's Protolabs position peaked at $695K in Q3 2019.
  • 262 funds tracked by Wall St. Rank held Protolabs as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.